Prevalence and Impact in Work Productivity of Gastroesophageal Reflux Disease (GERD) in Primary Care Patients With Upper Gastrointestinal (GI) Symptoms Using GerdQ

A Cross-sectional Study on the Prevalence and Impact in Work Productivity of GERD in Primary Care Patients With Upper GI Symptoms Using the Novel Questionnaire GERD-Q. The Greek GERD-Q Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00914342

Acronym

GerdQ-Greece

Enrollment

889

Registered

2009-06-05

Start date

2009-07-31

Completion date

2009-12-31

Last updated

2009-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal Reflux Disease

Keywords

Gerd, GerdQ questionnaire, work productivity, Greece

Brief summary

The purpose of the study is to provide data on the GERD prevalence as percentage of patients with upper GI symptoms that are identified with GERD using the GerdQ Questionnaire. Furthermore the study aims to estimate GERD prevalence in patients based on their symptoms as they respond to a physician's questionnaire, to observe possible variations between the two methods (physicians' symptom rating and GerdQ), to objectively measure treatment response and to identify the percentage of patients that may require alterations of their treatment. Finally, to describe the impact of GERD symptoms on work productivity.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients with upper-GI symptoms the last week prior visiting the investigator

Exclusion criteria

* History of oesophageal, gastric or duodenal surgery * Treatment with NSAIDs/Acetylsalicylic acid within the last week prior to the study visit * PPI use for healing of NSAIDs induced ulcer or for HP eradication

Design outcomes

Primary

Measure	Time frame
GERD prevalence as percentage of patients with upper GI symptoms that are identified with GERD using the GerdQ Questionnaire (GerdQ score >=8).	Single Visit - once

Secondary

Measure	Time frame
Estimation of GERD prevalence in patients based on their symptoms as they respond to a physician's questionnaire and to observe possible variations between the two methods (physicians' symptom rating and QerdQ)	Single Visit - Once
Describe the impact of GERD symptoms on work productivity.	Single Visit - Once
To objectively measure treatment response and to identify the percentage of patients that may require alterations of their treatment.	Single Visit - Once

Countries

Greece

Outcome results